Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03941275 · ClinicalTrials.gov registry record
SelectSecure 3830 Lead Imaging
A clinical trial of Heart Diseases, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 51
- Enrollment target
- 4
- Study locations
NCT03941275 is a study of Heart Diseases that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 51 participants, below the 5,532-participant average among 85 other Heart Diseases trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT03941275, a study of Heart Diseases, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is designed to collect high-quality shoulder and intracardiac bi-plane fluoroscopic images during two standard arm motions on patients implanted with a market released SelectSecure 3830 lead for the purposes of developing a fracture reliability model.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Bi-plane fluoroscopy
Study Locations (4)
Alabama
- Heart Center Research - Huntsville
Iowa
- Iowa Heart Center - West Des Moines
Maryland
- Associates in Cardiology PA - Silver Spring
New Jersey
- Lourdes Cardiology Services - Voorhees Township
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2019-05-24 |
| Est. Completion | 2021-11-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03941275
The ClinicalTrials.gov registry entry for NCT03941275 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,532-participant average among 85 other Heart Diseases trials with a reported enrollment target (99% lower). The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Diseases appearing as the primary indexed condition, and to 1 intervention - of which Bi-plane fluoroscopy is the first listed.
NCT03941275 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Alabama, Iowa, Maryland.
Frequently Asked Questions
What is clinical trial NCT03941275 about?
NCT03941275 is a clinical study titled "SelectSecure 3830 Lead Imaging". This study is designed to collect high-quality shoulder and intracardiac bi-plane fluoroscopic images during two standard arm motions on patients implanted with a market released SelectSecure 3830 lead for the purposes of developing a fracture reliability model.
What is the current status of trial NCT03941275?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2019-05-24. Estimated completion is 2021-11-15.
What conditions does trial NCT03941275 study?
This clinical trial studies the following conditions: Heart Diseases.
What interventions are being tested in trial NCT03941275?
The interventions under investigation include: Bi-plane fluoroscopy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03941275?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03941275 being conducted?
This trial has 4 study locations across Alabama, Iowa, Maryland, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Angiography and Electrogram Guided Bachmann Bundle Pacing
RECRUITING · NA
-
Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
RECRUITING · NA
-
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
RECRUITING · NA
-
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR
RECRUITING · NA
-
Lumason® Infusion vs. Bolus Administrations
RECRUITING · Phase 3
-
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.